Bank of Hawaii’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,378
| Closed | -$1.72M | – | 226 |
|
|
2025
Q4 | $1.72M | Buy |
9,378
+598
| +7% | +$105K | 0.09% | 101 |
|
|
2025
Q3 | $1.35M | Buy |
8,780
+649
| +8% | +$98.2K | 0.07% | 118 |
|
|
2025
Q2 | $1.14M | Buy |
8,131
+2,558
| +46% | +$359K | 0.06% | 124 |
|
|
2025
Q1 | $819K | Buy |
5,573
+1,302
| +30% | +$188K | 0.05% | 138 |
|
|
2024
Q4 | $560K | Sell |
4,271
-273
| -6% | -$38.2K | 0.03% | 170 |
|
|
2024
Q3 | $708K | Sell |
4,544
-668
| -13% | -$108K | 0.03% | 162 |
|
|
2024
Q2 | $813K | Sell |
5,212
-171
| -3% | -$25.7K | 0.04% | 146 |
|
|
2024
Q1 | $729K | Sell |
5,383
-985
| -15% | -$130K | 0.04% | 163 |
|
|
2023
Q4 | $858K | Sell |
6,368
-1,565
| -20% | -$203K | 0.05% | 142 |
|
|
2023
Q3 | $1.07M | Buy |
7,933
+777
| +11% | +$106K | 0.06% | 126 |
|
|
2023
Q2 | $1.02M | Buy |
7,156
+285
| +4% | +$41.9K | 0.06% | 129 |
|
|
2023
Q1 | $954K | Buy |
6,871
+1,347
| +24% | +$181K | 0.06% | 139 |
|
|
2022
Q4 | $749K | Sell |
5,524
-2,197
| -28% | -$276K | 0.05% | 147 |
|
|
2022
Q3 | $847K | Sell |
7,721
-5,921
| -43% | -$751K | 0.06% | 128 |
|
|
2022
Q2 | $1.8M | Sell |
13,642
-1,028
| -7% | -$135K | 0.11% | 88 |
|
|
2022
Q1 | $1.95M | Buy |
14,670
+14
| +0.1% | +$1.68K | 0.11% | 91 |
|
|
2021
Q4 | $1.71M | Sell |
14,656
-73
| -0.5% | -$8.59K | 0.09% | 100 |
|
|
2021
Q3 | $1.77M | Sell |
14,729
-274
| -2% | -$31.9K | 0.1% | 94 |
|
|
2021
Q2 | $1.8M | Sell |
15,003
-1,457
| -9% | -$160K | 0.1% | 101 |
|
|
2021
Q1 | $1.64M | Sell |
16,460
-432
| -3% | -$43.4K | 0.1% | 104 |
|
|
2020
Q4 | $1.69M | Sell |
16,892
-3,132
| -16% | -$332K | 0.11% | 98 |
|
|
2020
Q3 | $2.19M | Sell |
20,024
-1,590
| -7% | -$177K | 0.16% | 84 |
|
|
2020
Q2 | $2.29M | Sell |
21,614
-5,219
| -19% | -$539K | 0.17% | 75 |
|
|
2020
Q1 | $2.4M | Sell |
26,833
-1,118
| -4% | -$105K | 0.21% | 64 |
|
|
2019
Q4 | $2.79M | Sell |
27,951
-989
| -3% | -$93.1K | 0.19% | 67 |
|
|
2019
Q3 | $2.58M | Sell |
28,940
-922
| -3% | -$79.9K | 0.19% | 75 |
|
|
2019
Q2 | $2.46M | Sell |
29,862
-7,950
| -21% | -$623K | 0.18% | 81 |
|
|
2019
Q1 | $3.06M | Sell |
37,812
-4,250
| -10% | -$335K | 0.23% | 65 |
|
|
2018
Q4 | $3.19M | Sell |
42,062
-4,358
| -9% | -$340K | 0.28% | 58 |
|
|
2018
Q3 | $3.67M | Sell |
46,420
-2,740
| -6% | -$207K | 0.28% | 60 |
|
|
2018
Q2 | $3.45M | Sell |
49,160
-135
| -0.3% | -$9.71K | 0.29% | 61 |
|
|
2018
Q1 | $3.45M | Buy |
49,295
+440
| +0.9% | +$30.5K | 0.29% | 61 |
|
|
2017
Q4 | $3.39M | Buy |
48,855
+1,067
| +2% | +$72K | 0.28% | 70 |
|
|
2017
Q3 | $3.24M | Sell |
47,788
-6,592
| -12% | -$416K | 0.27% | 74 |
|
|
2017
Q2 | $3.71M | Buy |
54,380
+2,736
| +5% | +$179K | 0.32% | 59 |
|
|
2017
Q1 | $3.22M | Buy |
51,644
+8,410
| +19% | +$490K | 0.29% | 70 |
|
|
2016
Q4 | $2.36M | Buy |
43,234
+24,848
| +135% | +$1.41M | 0.22% | 85 |
|
|
2016
Q3 | $1.21M | Buy |
18,386
+4,450
| +32% | +$291K | 0.11% | 132 |
|
|
2016
Q2 | $841K | Buy |
13,936
+3,201
| +30% | +$186K | 0.09% | 174 |
|
|
2016
Q1 | $605K | Buy |
10,735
+3,522
| +49% | +$212K | 0.07% | 204 |
|
|
2015
Q4 | $490K | Buy |
+7,213
| New | +$473K | 0.06% | 249 |
|
|
2014
Q4 | – | Sell |
-7,337
| Closed | -$524K | – | 361 |
|
|
2014
Q3 | $524K | Sell |
7,337
-1,342
| -15% | -$98.2K | 0.05% | 241 |
|
|
2014
Q2 | $645K | Sell |
8,679
-134,737
| -94% | -$9.74M | 0.06% | 235 |
|
|
2014
Q1 | $9.3M | Sell |
143,416
-2,952
| -2% | -$191K | 0.93% | 18 |
|
|
2013
Q4 | $8.69M | Sell |
146,368
-6,482
| -4% | -$352K | 0.88% | 24 |
|
|
2013
Q3 | $7.94M | Buy |
152,850
+2,320
| +2% | +$117K | 0.83% | 26 |
|
|
2013
Q2 | $7.12M | Buy |
+150,530
| New | +$7.67M | 0.77% | 34 |
|
Other funds holding AZN
IA
VCM
VAM
Bank of Hawaii's AZN Position: Q1 2026 in Review
Bank of Hawaii sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 9,378 shares — an estimated $1.72M sold.
Bank of Hawaii first reported a position in AZN in Q2 2013 and held it in 47 quarters. The position peaked at $9.3M in Q1 2014. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Bank of Hawaii reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Bank of Hawaii sold 9,378 AstraZeneca shares in Q1 2026, an estimated $1.72M.
- Bank of Hawaii first reported a position in AstraZeneca in Q2 2013 and held it in 47 quarters.
- Bank of Hawaii's AstraZeneca position peaked at $9.3M in Q1 2014.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Bank of Hawaii's 13F filing for Q1 2026, filed 15 May 2026.